Table II.
CAS group (n=144)
|
Control group (n=64)
|
|||||
---|---|---|---|---|---|---|
Test | Baseline | 6 months after stenting | P-value | Baseline | 6 months after medication | P-value |
MMSE | 24.6±1.7 | 24.8±1.9 | 0.016 | 24.7±1.5 | 24.5±1.6 | 0.137 |
MOCA | 23.7±1.7 | 24.1±2.0 | 0.006 | 23.8±1.5 | 23.6±1.8 | 0.129 |
FOME | 13.8±2.2 | 14.0±2.3 | 0.031 | 14.2±2.3 | 14.1±2.5 | 0.171 |
RVR | 25.7±2.1 | 25.9±2.3 | 0.201 | 26.0±1.9 | 25.8±2.0 | 0.144 |
WAIS-DS | 6.7±2.1 | 6.9±2.3 | 0.040 | 6.8±2.0 | 6.6±1.9 | 0.158 |
ADL | 23.0±2.7 | 22.9±2.6 | 0.239 | 23.1±2.8 | 23.0±2.6 | 0.591 |
NIHSS | 0.72±1.16 | 0.67±1.05 | 0.294 | 0.69±1.15 | 0.63±1.00 | 0.415 |
CAS, carotid artery stenting; NIHSS, National Institutes of Health Stroke Scale; ADL, Activities of Daily Living; MMSE, Mini-Mental State Examination; MOCA, Montreal Cognitive Assessment; FOME, Fuld Object Memory Evaluation; RVR, rapid verbal retrieval; WAIS-DS, Wechsler Adult Intelligence Scale-digital span. Values are presented as mean ± standard deviation (SD).